Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Engber

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Neurologic Clinics|May 1, 1992
Molecular neuroanatomic mechanisms of Parkinson's disease: a proposed therapeutic approachC R Gerfen, T M Engber
Neuroscience Letters|December 19, 1988
Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatumT M Engber, T N Chase
Brain Research|August 21, 1992
Differential effect of subthalamic nucleus ablation on dopamine D1 and D2 agonist-induced rotation in 6-hydroxydopamine-lesioned ratsJ J Anderson, T N Chase, T M Engber
European Journal of Pharmacology|July 23, 1991
The kappa-opioid receptor agonist spiradoline differentially alters the rotational response to dopamine D1 and D2 agonistsT M Engber, R C Boldry, T N Chase
Neuroscience Letters|September 25, 1989
Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurementsZ Susel, T M Engber, T N Chase
Journal of Neurochemistry|October 1, 1985
Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brainS Manaker, T M Engber, P B Knight, et al.
Neurology|December 1, 1993
Motor response complications and the function of striatal efferent systemsT N Chase, M M Mouradian, T M Engber
Brain Research|October 1, 1993
Substance P increases release of acetylcholine in the dorsal striatum of freely moving ratsJ J Anderson, T N Chase, T M Engber
Neurology|July 1, 1994
Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's diseaseT N Chase, T M Engber, M M Mouradian
Advances in Neurology|January 1, 1993
Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's diseaseT N Chase, T M Engber, M M Mouradian
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Neurologic Clinics|May 1, 1992
Molecular neuroanatomic mechanisms of Parkinson's disease: a proposed therapeutic approachC R Gerfen, T M Engber
Neuroscience Letters|December 19, 1988
Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatumT M Engber, T N Chase
Brain Research|August 21, 1992
Differential effect of subthalamic nucleus ablation on dopamine D1 and D2 agonist-induced rotation in 6-hydroxydopamine-lesioned ratsJ J Anderson, T N Chase, T M Engber
European Journal of Pharmacology|July 23, 1991
The kappa-opioid receptor agonist spiradoline differentially alters the rotational response to dopamine D1 and D2 agonistsT M Engber, R C Boldry, T N Chase
Neuroscience Letters|September 25, 1989
Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurementsZ Susel, T M Engber, T N Chase
Journal of Neurochemistry|October 1, 1985
Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brainS Manaker, T M Engber, P B Knight, et al.
Neurology|December 1, 1993
Motor response complications and the function of striatal efferent systemsT N Chase, M M Mouradian, T M Engber
Brain Research|October 1, 1993
Substance P increases release of acetylcholine in the dorsal striatum of freely moving ratsJ J Anderson, T N Chase, T M Engber
Neurology|July 1, 1994
Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's diseaseT N Chase, T M Engber, M M Mouradian
Advances in Neurology|January 1, 1993
Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's diseaseT N Chase, T M Engber, M M Mouradian
Pageof 5